These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32503999)

  • 1. Unconventional CD45RA+ memory CD8 T cells to control HIV infection during antiretroviral therapy.
    Rolot M; Dewals BG
    Cell Mol Immunol; 2020 Sep; 17(9):897-898. PubMed ID: 32503999
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.
    Yin L; Rodriguez CA; Hou W; Potter O; Caplan MJ; Goodenow MM; Sleasman JW
    J Allergy Clin Immunol; 2008 Jul; 122(1):166-72, 172.e1-2. PubMed ID: 18538835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.
    Nicholson JK; Browning SW; Hengel RL; Lew E; Gallagher LE; Rimland D; McDougal JS
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):105-15. PubMed ID: 11404531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART).
    Colle JH; Moreau JL; Fontanet A; Lambotte O; Joussemet M; Delfraissy JF; Thèze J
    Clin Exp Immunol; 2006 Mar; 143(3):398-403. PubMed ID: 16487237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
    J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy.
    Pohling J; Zipperlen K; Hollett NA; Gallant ME; Grant MD
    BMC Infect Dis; 2010 May; 10():129. PubMed ID: 20500844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
    AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
    Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
    AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
    Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
    Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.
    Resino S; Galán I; Pérez A; León JA; Seoane E; Gurbindo D; Muñoz-Fernandez MA
    Clin Exp Immunol; 2004 Sep; 137(3):570-7. PubMed ID: 15320908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of naïve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population.
    Roman M; Rodriguez JW; Pagán NO; Rios-Olivares E; Amill A; Hunter R
    P R Health Sci J; 2002 Sep; 21(3):195-201. PubMed ID: 12243109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children.
    Bekker V; Bronke C; Scherpbier HJ; Weel JF; Jurriaans S; Wertheim-van Dillen PM; van Leth F; Lange JM; Tesselaar K; van Baarle D; Kuijpers TW
    AIDS; 2005 Jul; 19(10):1025-34. PubMed ID: 15958833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children.
    Kou ZC; Puhr JS; Wu SS; Goodenow MM; Sleasman JW
    J Infect Dis; 2003 Feb; 187(3):385-97. PubMed ID: 12552422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosenescence of the CD8(+) T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue, metabolism, and muscle in antiretroviral therapy-treated HIV-infected patients and controls.
    Tavenier J; Langkilde A; Haupt TH; Henriksen JH; Jensen FK; Petersen J; Andersen O
    BMC Immunol; 2015 Nov; 16():72. PubMed ID: 26611787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging.
    Lee SA; Sinclair E; Hatano H; Hsue PY; Epling L; Hecht FM; Bangsberg DR; Martin JN; McCune JM; Deeks SG; Hunt PW
    PLoS One; 2014; 9(2):e89444. PubMed ID: 24586783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption.
    D'Offizi G; Montesano C; Agrati C; Gioia C; Amicosante M; Topino S; Narciso P; Pucillo LP; Ippolito G; Poccia F
    AIDS; 2002 Dec; 16(18):2431-8. PubMed ID: 12461417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD31 (PECAM-1) is a marker of recent thymic emigrants among CD4+ T-cells, but not CD8+ T-cells or gammadelta T-cells, in HIV patients responding to ART.
    Tanaskovic S; Fernandez S; Price P; Lee S; French MA
    Immunol Cell Biol; 2010; 88(3):321-7. PubMed ID: 20065992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.